These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8236116)

  • 1. Factor VIII structure and function.
    Fay PJ
    Thromb Haemost; 1993 Jul; 70(1):63-7. PubMed ID: 8236116
    [No Abstract]   [Full Text] [Related]  

  • 2. von Willebrand factor/factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factor.
    Nesbitt IM; Goodeve AC; Preston FE; Peake IR
    Thromb Haemost; 1996 Nov; 76(5):820-1. PubMed ID: 8950801
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of factor VIII expression and activity by von Willebrand factor.
    Kaufman RJ; Pipe SW
    Thromb Haemost; 1999 Aug; 82(2):201-8. PubMed ID: 10605705
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure and function of the factor VIII gene and protein.
    Thompson AR
    Semin Thromb Hemost; 2003 Feb; 29(1):11-22. PubMed ID: 12640560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Components and assembly of the factor X activating complex.
    Ahmad SS; Rawala-Sheikh R; Walsh PN
    Semin Thromb Hemost; 1992; 18(3):311-23. PubMed ID: 1455249
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII and von Willebrand factor.
    Vlot AJ; Koppelman SJ; Bouma BN; Sixma JJ
    Thromb Haemost; 1998 Mar; 79(3):456-65. PubMed ID: 9531024
    [No Abstract]   [Full Text] [Related]  

  • 8. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant von Willebrand disease with defective binding to factor VIII: the first case from Japan.
    Nishino M; Miura S; Yoshioka A; Kuwahara I; Nishimura T; Hamada K; Fukui H
    Int J Hematol; 1993 Apr; 57(2):163-73. PubMed ID: 8494994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current insights in factor VIII biology].
    Sixma JJ; Hamer RJ; Koedam J
    Ned Tijdschr Geneeskd; 1986 Nov; 130(45):2026-30. PubMed ID: 3095668
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate).
    Stadler M; Gruber G; Kannicht C; Biesert L; Radomski KU; Suhartono H; Pock K; Neisser-Svae A; Weinberger J; Römisch J; Svae TE
    Biologicals; 2006 Dec; 34(4):281-8. PubMed ID: 16500114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII.
    Rick ME; Krizek DM
    Am J Hematol; 1996 Apr; 51(4):302-6. PubMed ID: 8602631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH.
    Mazurier C; Meyer D
    Thromb Haemost; 1996 Aug; 76(2):270-4. PubMed ID: 8865544
    [No Abstract]   [Full Text] [Related]  

  • 16. Factor VIII - novel insights into form and function.
    Saenko EL; Ananyeva NM; Tuddenham EG; Kemball-Cook G
    Br J Haematol; 2002 Nov; 119(2):323-31. PubMed ID: 12406064
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
    Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of von Willebrand disease.
    Mazurier C; Ribba AS; Gaucher C; Meyer D
    Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factor VIII/von Willebrand factor complex: basic and clinical issues.
    Federici AB
    Haematologica; 2003 Jun; 88(6):EREP02. PubMed ID: 12826528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physical exchange of factor VIII (FVIII) between von Willebrand factor and activated platelets and the effect of the FVIII B-domain on platelet binding.
    Li X; Gabriel DA
    Biochemistry; 1997 Sep; 36(35):10760-7. PubMed ID: 9271507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.